Clinical Trial Update: Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing CARTO 3 system-guided THERMOCOOL catheter ablation with PVAC ablation for atrial fibrillation; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CARTO 3 System
• Pulmonary Vein Ablation Catheter (PVAC) (PVAC)
• THERMOCOOL Catheter (ThermoCool Catheter)

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED